Medical Devices industry cross border deals total $807.8m globally in September 2022

Total medical devices industry cross border deals worth $807.8m were announced globally for September 2022, with the $243.32m acquisition of Medi-Globe being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked a decrease of 82.7% over the previous month of $4.67bn and a drop of 73.3% when compared with the last 12-month average of $3.02bn.

In terms of number of cross border deals, the sector saw a drop of 23.44% with 49 deals in September 2022 when compared to the last 12-month average of 64 deals.

In value terms, Europe led the activity with cross border deals worth $400.85m in September 2022.

Medical Devices industry cross border deals in September 2022: Top deals

The top five cross border deals accounted for 69.5% of the overall value during September 2022.

The combined value of the top five cross border deals stood at $561.28m, against the overall value of $807.8m recorded for the month.

The top five medical devices industry cross border deals of September 2022 tracked by GlobalData were:

1) DCC Healthcare’s $243.32m acquisition deal with Medi-Globe

2) The $154.02m acquisition of IZI Medical Products by Halma

3) Bluestem Capital Company, Falcon Vision Global, Marshall Wace and MVM Partners’s $67m venture financing deal with Neurolenses

4) The $50m venture financing of Ceribell by Ally Bridge Group

5) 415 Capital Management, Andera Partners, BioMedPartners, Credit Mutuel Innovation, Go Capital , Karista and Wellington Partners Venture Capital’s $46.94m venture financing deal with TRiCares